SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-040306
Filing Date
2013-02-06
Accepted
2013-02-06 10:30:23
Documents
10
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d446258d10q.htm 10-Q 538646
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302(A) d446258dex311.htm EX-31.1 9580
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302(A) d446258dex312.htm EX-31.2 9781
4 CERTIFICATIONS PURSUANT TO SECTION 906 d446258dex321.htm EX-32.1 4516
  Complete submission text file 0001193125-13-040306.txt   4549752

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mygn-20121231.xml EX-101.INS 756556
6 XBRL TAXONOMY EXTENSION SCHEMA mygn-20121231.xsd EX-101.SCH 42004
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mygn-20121231_cal.xml EX-101.CAL 64435
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mygn-20121231_def.xml EX-101.DEF 219071
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20121231_lab.xml EX-101.LAB 321637
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20121231_pre.xml EX-101.PRE 260666
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 13576564
SIC: 2835 In Vitro & In Vivo Diagnostic Substances